Red wine and cardiovascular risks

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 12, 2006, Pages 1230-1235

  Lagrue Lak Hal, A H ^b   Andriantsitohaina, R ^a  

^a Universite d'Angers   (France)

^b NONE

Author keywords

Alcohol; Cardiovascular disease; endothelium; Red wine polyphenols

Indexed keywords

ANTICOAGULANT AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CATECHIN; CYANIDIN CHLORIDE; DELPHINIDIN; EPICATECHIN; FLAVONOID; KAEMPFEROL; MYRICETIN; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; QUERCETIN; TANNIN DERIVATIVE; VASODILATOR AGENT;

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; HEMOSTASIS; HUMAN; LIPID ANALYSIS; NONHUMAN; RED WINE; REVIEW; THROMBOSIS;

ALCOHOL DRINKING; ANIMALS; AORTA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COLOR; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; MODELS, ANIMAL; PHENOLS; RISK ASSESSMENT; STILBENES; THROMBOSIS; VASCULAR DISEASES; VASODILATOR AGENTS; WINE;

EID: 33846881806     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337:1705-14.
2. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000;95:1505-23.
3. Szmitko PE, Verma S. Antiatherogenic potential of red wine: clinician update. Am J Physiol Heart Circ Physiol 2005;288:2023-30.
4. St Legar AS, Moore F, Cochrane AL. Factors associated with cardiomortality in developed countries with particular reference to consumption of wine. Lancet 1979/1:1017-20.
5. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-44.
6. Gronbaek M. Alcohol, type of alcohol, and all-cause and coronary heart disease mortality. Ann NY Acad Sci 2002;957:16-20.
7. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
8. Klatsky AL, Armstrong MA, Friedman GD. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol 1997;80:416-20.
9. Gaziano JM, Hennekens CH, Godfried SL, et al. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol 1999;83:52-7.
10. Cuevas AM, Guasch V, Castillo O, et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids 2000;35:143-8.
11. De Oliveira E, Silva ER, Foster D, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000;102:2347-52.
12. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Enql J Med 1993;329:1829-34.
13. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999;319:1523-8.
14. Dashti N, Franklin FA, Abrahamson DR. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells. J Lipid Res 1996;37:810-24.
15. Di Bari M, Zacchei S, Kritchevsky SB, et al. Anti-oxidized LDL antibodies and wine consumption: a population-based epidemiological study in Dicomano, Italy. Ann Epidemiol 2003;13:189-95.
16. Schroder H, Marrugat J, Fito M, Weinbrenner T, Covas MI. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein. Free Radic Biol Med 2006;40:1474-81.
17. Estruch R, Sacanella E, Badia E, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 2004;175:117-23.
18. Ridker, PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8.
19. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
20. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-5.
21. Imhof A, Froehlich M, Brenner H, et al. Antiinflammatory effects of moderate alcohol consumption: a link to mortality (abstr)? Eur Heart J 2000;21:497.
22. Mennen LI, Balkau B, Vol S, Caces E, Eschwedge E. Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999;19:887-92.
23. Mukamal KJ, Jadhav PP, D'Agostiono RB. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001;104:1367-73.
24. Rogers S, Yarnell JWG, Fehily AM. Nutritional determinants of haemostatic factors in the Caerphilly study. Eur J Clin Nutr 1998;42:197-05.
25. Lacoste L, Hung J, Lam JYT. Acute and delayed antithrombic effects of alcohol in humans. Am J Cardiol 2001;87:82-5.
26. Stubbs CD, Rubin R. Effect of ethanol on platelet phospholipase A2. Lipids 1992;27:255-60.
27. Venkov CD, Myers PR, Tanner MA, Su M, Vaughan DE. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost 1999;81:638-42.
28. Bau PF, Bau CH, Naujorks AA, Rosito GA. Early and late effects of alcohol ingestion on blood pressure and endothelial function. Alcohol 2005;37:53-8.
29. Zilkens RR, Burke V, Hodgson JM, Barden A, Beilin LJ, Puddey IB. Red wine and beer elevate blood pressure in normotensive men. Hypertension 2005;45:874-9.
30. Cordova AC, Jackson LS, Berke-Schlessel DW, Sumpio BE. The cardiovascular protective effect of red wine. J Am Coll Surg 2005;200:428-39.
31. Curin Y, Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep. 2005;57 Suppl:97-107.
32. Curin Y, Ritz MF, Andriantsitohaina R. Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc Hematol Agents Med Chem 2006;4:229-35.
33. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: Effects of quercetin and wine polyphenols. Free Radical Research 2006;40:1054-65.
34. Middleton E Jr, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-51.
35. Pannala AS, Rice-Evans CA, Halliwell B, Singh S: Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 1997;232:164-8.
36. Binsack R, Boersma BJ, Patel RP, et al. Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid. Alcohol Clin Exp Res 2001;25:434-43.
37. Nijveldt RJ, van Nood E, van Hoorn DE, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25.
38. Korkina LG, Afanas'ev IB. Antioxidant and chelating properties of flavonoids. Adv Pharmacol 1997;38:151-63.
39. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S-8S.
40. Krinsky NI. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992;200:248-54.
41. Orallo F, Alvarez E, Camina M, et al. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 2002;61:294-302.
42. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
43. Ou HC, Chou FP, Sheen HM, et al. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Acta 2006;364:196-204.
44. Vinson JA, Teufel K, Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2001;156:67-72.
45. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999;100:1050-5.
46. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
47. Naissides M, Mamo JC, James AP, Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis 2006;185:438-45.
48. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65.
49. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994;344:193-4.
50. de Rijke YB, Demacker PN, Assen NA, Sloots LM, Katan MB, Stalenhoef AF. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am J Clin Nutr 1996;63:329-34.
51. Zern TL, Wood RJ, Greene C, et al. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005;135:1911-7.
52. Naissides M, Pal S, Mamo JC, James AP, Dhaliwal S. The effect of chronic consumption of red wine polyphenols on vascular function in postmenopausal women. Eur J Clin Nutr 2006;60:740-5.
53. Del Bas JM, Fernández-Larrea J, Blay M, et al. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. FASEB J 2005;19:479-81.
54. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
55. Marques-Vidal P, Cambou JP, Nicaud V, et al. Cardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis 1995;115:225-32.
56. Perret B, Ruidavets JB, Vieu C, et al. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol Clin Exp Res 2002;26:1134-40.
57. Ferrandiz ML, Alcaraz MJ. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991;32:283-8.
58. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991;42:1673-81.
59. Kim HP, Mani I, Iversen L, Ziboh VA. Effects of naturally-occur-ring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guineapigs. Prostaglandins Leukot Essent Fatty Acids 1998;58:17-24.
60. Badia E, Sacanella E, Fernandez-Sola J, et al. Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption. Am J Clin Nutr 2004;80:225-30.
61. de Gaetano G, De Curtis A, di Castelnuovo A, Donati MB, Iacoviello L, Rotondo S. Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption. Ann N Y Acad Sci 2002;957:174-88.
62. Xia J, Allenbrand B, Sun GY. Dietary supplementation of grape polyphenols and chronic ethanol administration on LDL oxidation and platelet function in rats. Life Sci 1998;63 383-90.
63. Dell'Agli M, Busciala A, Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res 2004;63:593-02.
64. Rein D, Paglieroni TG, Pearson DA, et al. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 2000;130:2120-6S.
65. Russo P, Tedesco I, Russo M, Russo GL, Venezia A, Cicala C. Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutr Metab Cardiovasc Dis 2001;11:2-9.
66. Rechner AR, kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res 2005;116:327-34.
67. Freedman JE, Parker C, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001;103:2792-8.
68. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, and Golberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;35:207-19.
69. Moon SK, Cho GO, Jung SY, et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 2003;301:1069-78.
70. Yoshizumi M, Tsuchiya K, Suzaki Y, et al. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 2002;293:1458-65.
71. Iijima K, Yoshizumi M, Hashimoto, et al. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 2000;101:805-11.
72. Feng AN, Chen YL, Chen YT, Ding YZ, Lin SJ. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits. Circulation 1999;100:2254-9.
73. Elbaz M, Roul G, Alvès A, Andriantsitohaina R. Provinols, a polyphenolic extract of red wine inhibits in-stent neointimal growth in cholesterol-fed rabbit (Abstract). Arch Mal Cœur Vaiss 2005;98:406.
74. Andriambeloson E, Kleschyov AL, Muller B, Beretz A, Stoclet JC, Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 1997;120:1053-8.
75. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endotheliumdependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993;265:H774-8.
76. Duarte J, Andriambeloson E, Diebolt M, Andriantsitohaina R. Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelialdependent vasodilatation. Physiol Res 2004;53:595-602.
77. Zenebe W, Pechanova O, Andriantsitohaina R. Red wine polyphenols induce vasorelaxation by increased nitric oxide bioactivity. Physiol Res 2003;52:425-32.
78. Ndiaye M, Chataigneau T, Andriantsitohaina R, Stoclet JC, Schini-Kerth VB. Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem Biophys Res Commun 2003;310:371-7.
79. Corder R, Douthwaite JA, Lees DM, et al. Endothelin-1 synthesis reduced by red wine. Nature 2001;414:863-4.
80. Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001;38:159-65.
81. Pechanova O, Bernatova II Babal P, et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME induced hypertension. J Hypertens 2004;22:1551-9.
82. Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002;282:H942-8.
83. Sarr M, Chataigneau M, Martins S, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats : Role of NADPH oxidase. Cardiovascular research 2006;71:794-802.
84. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol 1999;33:248-54.
85. Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. BrJ Pharmacol 2002;135:1579-87.
86. Ndiaye M, Chataigneau M, Lobysheva I, Chataigneau T, Schim-Kerth VB. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive Plo-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J 2005;19:455-7.
87. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-8.
88. Matsuo S, Nakamura Y, Takahashi M, et al. Effect of red wine and ethanol on production of nitric oxide in healthy subjects. Am J Cardiol 2001;87:1029-31:A6.
89. Hozumi T, Sugioka K, Shimada K, et al. Beneficial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 2006;92:681-2.
90. Ranaivo HR, Diebolt M, Andriantsitohaina R. Wine polyphenols induce hypotension and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide. Br J Pharmacol 2004;142:671-8.